Transaction DateRecipientSharesTypePriceValue
23rd April 2020Robert Grant Edwards2,609Grant/award etc.$0.00
23rd April 2020Poggetto John Dal3,086Grant/award etc.$0.00
Sonoma Pharmaceuticals
Sonoma Pharmaceuticals logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 7/10.

Sonoma Pharmaceuticals, Inc. engages in identifying, developing, and commercializing therapies for chronic skin conditions. The company offers solutions in dermatology, animal healthcare, and advanced tissue care product areas. Its products target skin diseases including acne, atopic dermatitis, scarring, infections, itch, pain, and harmful inflammatory responses.

Ticker: SNOA
Sector: Health Technology
Industry: Pharmaceuticals: Other
SEC Central Index Key (CIK): 1367083
Employees: 298
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags